GGrantIndex
← Search

Cancer Prevention, Control, and Population Research Program

$43,814P30FY2018CANIH

Case Western Reserve University, Cleveland OH

Investigators

Linked publications, trials & patents

Trial NCT05340673Trial NCT05198830Trial NCT02590107Trial NCT02535325Trial NCT02451124Trial NCT02419846Trial NCT02417948Trial NCT02392377Trial NCT02388932Trial NCT02383433Trial NCT02375477Trial NCT02354326Trial NCT02345460Trial NCT02342730Trial NCT02337465Trial NCT02327390Trial NCT02319889Trial NCT02307474Trial NCT02287636Trial NCT02252393Trial NCT02181478Trial NCT02179762Trial NCT02163317Trial NCT02158767Trial NCT02153450Trial NCT02135562Trial NCT02131207Trial NCT02129582Trial NCT02129569Trial NCT02129517Trial NCT02129218Trial NCT02128373Trial NCT02108587Trial NCT02100423Trial NCT02084147Trial NCT02082405Trial NCT02081794Trial NCT02079155Trial NCT02073097Trial NCT02073045Trial NCT02071901Trial NCT02070458Trial NCT02070419Trial NCT02055586Trial NCT02037048Trial NCT01973062Trial NCT01959490Trial NCT01959477Trial NCT01954784Trial NCT01954732Trial NCT01951885Trial NCT01939028Trial NCT01928485Trial NCT01894061Trial NCT01408043Trial NCT00991991Trial NCT00970684Trial NCT00961220Trial NCT00956475Trial NCT00952939Trial NCT00949247Trial NCT00945061Trial NCT00941720Trial NCT00941070Trial NCT00939510Trial NCT00918892Trial NCT00918788Trial NCT00918658Trial NCT00918216Trial NCT00910039Trial NCT00909662Trial NCT00908739Trial NCT00908141Trial NCT00907699Trial NCT00905086Trial NCT00900133Trial NCT00899158Trial NCT00899132Trial NCT00898573Trial NCT00898274Trial NCT00897143Trial NCT00892385Trial NCT00873600Trial NCT00873002Trial NCT00866320Trial NCT00856115Trial NCT00853021Trial NCT00842452Trial NCT00809185Trial NCT00796978Trial NCT00795678Trial NCT00769951Trial NCT00769249Trial NCT00752323Trial NCT00740961Trial NCT00736216Trial NCT00735514Trial NCT00733252Trial NCT00732745Trial NCT00732173

Abstract

CANCER PREVENTION, CONTROL AND POPULATION RESEARCH (CPC) PROGRAM PROJECT SUMMARY/ABSTRACT The goal of the Cancer Prevention, Control and Population Research (CPC) Program is to develop and evaluate interventions that reduce the incidence and improve the outcomes of cancer in the Case Comprehensive Cancer Center (Case CCC) catchment area and beyond. Program members establish novel approaches in risk reduction, screening, and early detection. They also conduct research to implement and monitor improved delivery of recommended preventive services, therapies, and survivorship care after cancer diagnosis. The program is organized around 3 scientific aims: (1) Discover strategies and develop and implement behavioral interventions to reduce cancer risk and improve outcomes after cancer diagnosis; (2) Evaluate and facilitate effective cancer screening, surveillance and treatment policies and their impact on practice and the healthcare system; and (3) Discover and characterize genetic and environmental factors linked to cancer. These aims reflect major working groups and initiatives that coalesces program members with other cancer center investigators through inter-programmatic collaborations that have impacted paradigms for patient care, health policy and the larger cancer research community. Extensive use of an array of shared resources, in particular Biostatistics, Cancer Outcomes, Genomics, and Tissue facilitate all aspects of member discoveries. Under the leadership of Gregory Cooper (Co-Leader) and Susan Flocke (Co-Leader) the CPC Program has 38 members including 30 full, 1 associate, and 7 clinical members. Members represent 20 departments, giving rise to a total of $10.8M in grant funding (annual direct costs), of which $8.2M is peer-reviewed and $2.3M is NCI-funded. Between 2012 and 2016, CPC program members published 1,174 publications. Cancer and program related publications included 25% inter-programmatic, 16% intra-programmatic, 6% inter- and intra- programmatic and 11% that involved collaborations with another Cancer Center. This highly effective Program has successfully created synergy among Case CCC CPC members and collaborations with investigators in other research Programs as evidenced by new initiatives in cancer prevention in underserved urban populations, tobacco control, new approaches to colon cancer screening and prevention, palliative care of patients with advanced cancer, and cancer risk in HIV infected individuals.

View original record on NIH RePORTER →